Balaxi Pharmaceuticals has developed a strategy to expand its portfolio of proprietary and niche branded formulations based on the experience that it has gained in the last two years in the Latin American markets. It has decided to invest in establishing in-house capabilities for researching, developing and manufacturing differentiated formulations in these markets with innovative delivery systems.
The Company intends to seek Board approvals to acquire 3-5 acres of land to establish its first manufacturing location near Hyderabad, in the Pharma SEZ, Jadcherla, Telangana. It intends to establish a greenfield WHO-GMP/PICS certified manufacturing facility. This facility will be specifically focusing on expanding the portfolio of differentiated branded formulations.
Balaxi Pharmaceuticals operates as an investment company in India.
| Company Name | CMP |
|---|---|
| Redington | 234.90 |
| Adani Enterprises | 2218.35 |
| Amrapali Industries | 17.53 |
| Rashi Peripheral | 455.25 |
| PDS | 301.45 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: